<DOC>
<DOCNO>EP-0614665</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Use of beer draff extract for the preparation of oral compositions
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K36899	A61P3700	A61K3600	A23L110	A61P3708	A23L130	A23L130	A23L110	A61K3600	A61K3688	A61K3606	A61K36066	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61P	A61K	A23L	A61P	A23L	A23L	A23L	A61K	A61K	A61K	A61K	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K36	A61P37	A61K36	A23L1	A61P37	A23L1	A23L1	A23L1	A61K36	A61K36	A61K36	A61K36	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Medicinal compositions which are to be administered orally for the treatment of skin disorders or as dietetic foodstuffs are prepared using beer draff extract(s) - in particular a beer draff extract obtained using liquid or supercritical CO2 or N2O.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
PENTAPHARM AG
</APPLICANT-NAME>
<APPLICANT-NAME>
PENTAPHARM AG
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
DRILLER HANSJUERGEN DR
</INVENTOR-NAME>
<INVENTOR-NAME>
TRONNIER HAGEN PROF DR
</INVENTOR-NAME>
<INVENTOR-NAME>
DRILLER, HANSJUERGEN, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
TRONNIER, HAGEN, PROF. DR.
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
Use of spent-grain extract for the preparation of medicinal formulations to
be administered orally for the treatment of skin diseases, in particular those

which are accompanied by itching and/or inflammatory symptoms.
Use of spent-grain extract according to claim 1, wherein it is used for the
treatment of dermatitis atopica, ichthyosis, desiccation eczema, pruritus,

sebostasis, dermatomycoses and jellyfish burns.
Use of spent-grain extract according to claim 1 or 2, wherein the spent-grain
extract has been obtained by means of liquid or supercritical CO
2
 or N
2
O.
Use of spent-grain extract according to one or several of the claims 1 to
3, wherein the administration occurs in the form of hard-gelatin or soft-gelatin

capsules or microcapsules.
Use of spent-grain extract according to one or several of the claims 1 to
4, wherein the concentration of unsaturated fatty acids is normalized or

increased in skin and in serum of human beings.
Use of spent-grain extract for the production of dietetic foodstuffs.
Use of spent-grain extract according to claim 6, wherein the
concentration of unsaturated fatty acids is normalized or increased in skin and

in serum of human beings.
Use of spent-grain extract according to claim 6 or 7, wherein the spent-grain
extract has been obtained by means of liquid or supercritical CO
2
 or N
2
O.
Use of spent-grain extract according to one or several of the claims 6 to
8, wherein the administration occurs in the form of hard-gelatin or soft-gelatin

capsules or microcapsules.
</CLAIMS>
</TEXT>
</DOC>
